Establishing the financial burden of alopecia areata and its predictors

Author:

Zucchelli Fabio1,Harries Matthew23,Messenger Andrew4ORCID,Montgomery Kerry5

Affiliation:

1. Centre for Appearance Research University West of the England Bristol UK

2. Salford Royal Hospital Northern Care Alliance NHS Foundation Trust Manchester Academic Health Science Centre Manchester UK

3. Centre for Dermatology Research Faculty of Biology, Medicine and Health University of Manchester Manchester UK

4. University of Sheffield Sheffield UK

5. Alopecia UK Shipley UK

Abstract

AbstractBackgroundAlopecia areata (AA) can have a significant impact on wellbeing. Consequently, individuals with AA often seek treatments or products to promote hair regrowth or camouflage their hair loss that incur a financial cost to the individual.ObjectivesThe current study aimed to examine the direct financial burden of AA to understand the wider impact of the condition and the factors which influence spending on products and services.MethodsA total of 829 United Kingdom based participants completed an online survey. Demographic and condition‐specific data were collected, alongside spending on AA‐related products and services. Participants were asked about their use of products and services, the associated costs, how they financed these costs, and their household income to determine what percentage of income they spent on products and services.ResultsParticipants predominantly identified as female (85.9%), white (92.7%) with a mean age of 42.7 years and a median AA duration of 10.94 years. Female gender, Asian ethnicity, lower income, and worse AA symptoms predicted higher spend from income. Wigs were the most common product used and incurred the greatest cost (median £700). The highest cost for men was private dermatology services (median = £550). On average people spent 3% of their disposable income (prior to housing costs) on AA‐related products and services.ConclusionsThis study outlines the risk factors associated with higher financial burden from managing AA which require consideration by health providers, commissioners, and policy makers when designing services to support the wellbeing of people living with AA.

Funder

Pfizer

Publisher

Wiley

Subject

Dermatology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3